article thumbnail

Subcutaneous Medications and Drug Delivery Systems

Roots Analysis

Advent of Innovative Drug Delivery Systems has Also Unfolded Many Novel Opportunities In addition, a number of device manufacturers have emerged with their novel drug delivery systems that facilitate subcutaneous administration; we identified over 200 such systems.

article thumbnail

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Bio Pharma Dive

Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transdermal and Microneedle Drug Delivery 2023

pharmaphorum

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.

article thumbnail

Sandoz bulks up ahead of possible sale with Coalesce buy

pharmaphorum

This morning, Sandoz announced it has acquired medical and drug delivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics. The post Sandoz bulks up ahead of possible sale with Coalesce buy appeared first on.

Sales 97
article thumbnail

Satsuma submits new drug application for STS101 to the US FDA

Pharmaceutical Technology

Satsuma shareholders will receive the CVR subject to the future sale, licence or any other monetisation events related to Satsuma’s new investigational therapeutic product, STS101. In March 2023, Satsuma submitted a new drug application for STS101 to the US Food and Drug Administration (FDA). in cash per share.

Drugs 147
article thumbnail

Evotec, Chinook Teams Up for CKD Therapy; HitGen & UPPTHERA in Drug Delivery Research; Artiva’s $120 M Coup of NK Cell Therapy; Junshi & AZ with Toripalimab in China

Delveinsight

To sum it, Chinook will manage clinical development and commercialization of product candidates while Evotec will be eligible for an undisclosed upfront payment, research funding, progress-dependent milestone payments, and tiered royalties on net sales for targets identified through the collaboration.

article thumbnail

International gang including UK criminals sentenced for illegal supply and sale of prescription drugs

Outsourcing Pharma

Two men have been jailed and another handed a suspended sentence, for selling more than three million doses of prescription-only and unlicensed medicines, including controlled medicines.

Sales 52